ELIZABETH BECKER: Open Payments
NPI 1235839861 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,936 in 141 payments from 18 companies in 2025. Trend: 2023 $1,306 · 2024 $1,685 · 2025 $1,936
Food & beverage: $1,920Education: $16
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 58 | $515 |
| Novo Nordisk Inc | 15 | $359 |
| Madrigal Pharmaceuticals | 24 | $293 |
| Corcept Therapeutics | 13 | $150 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| Sequel Med Tech, LLC | 1 | $73 |
| Amneal Pharmaceuticals LLC | 4 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| ABBVIE INC. | 4 | $67 |
| Amgen Inc. | 3 | $56 |
Products named: Dexcom G6 Transmitter, REZDIFFRA, Korlym, Wegovy, Ozempic, DEXCOM G7 GSS (161), Sogroya, CRENESSITY.
Industry payments across PA — which companies pay providers there.
